Pulmonary arterial ... Certain types of liver disease, like cirrhosis, can cause high blood pressure in the blood vessels to the liver, known as portal hypertension. This can, in turn, lead ...

Frank hemoptysis occurred in 5 patients, all of whom had moderate to marked pulmonary hypertension. The average pulmonary-artery pressure for this group was 61 systolic, 33 diastolic. Seven ...

Current drugs available for the treatment of primary arterial hypertension ... SERT and the 5-hydroxytryptamine (5-HT) 1B receptor cooperate in mediation of serotonin-induced pulmonary ...

Supporters will unite on May 5 to mark World Pulmonary Hypertension Day, with a focus this year on early diagnosis.

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

The drug has been approved for two types of pulmonary hypertension: • for patients with chronic thromboembolic pulmonary hypertension (CTEPH) after surgery or patients who cannot undergo surgery ...

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis" has shed light on the potential of pulmonary ...

Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary artery denervation (PADN) as an innovative intervention for ...